Used in pharmaceutical research as an intermediate in the synthesis of potent kinase inhibitors, particularly targeting TRK (tropomyosin receptor kinase) proteins. It plays a key role in developing anticancer agents due to its ability to selectively bind and modulate signaling pathways involved in tumor growth and survival. Its structure supports high affinity binding, making it valuable in creating targeted therapies for cancers with NTRK gene fusions. Also explored in the development of neurotrophic agents for neurodegenerative conditions.